Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA): description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change: description of variant at RNA level (following HGVS recommendations).
- r.123c>u
- r.? = unknown
- r.(?) = RNA not analysed but probably transcribed copy of DNA variant
- r.spl? = RNA not analysed but variant probably affects splicing
- r.(spl?) = RNA not analysed but variant may affect splicing
- r.0? = change expected to abolish transcription
Protein: description of variant at protein level (following HGVS recommendations).
- p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
- p.Arg345Pro = change derived from RNA analysis
- p.? = unknown effect
- p.0? = probably no protein produced
P-domain: region/domain protein affected
Allele: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method: The method used for the clinical classification of this variant.
All options:
- ACMG
- ACGS
- EAHAD-CFDB
- ENIGMA
- IARC
- InSiGHT
- kConFab
- other
Clinical classification: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
- pathogenic
- pathogenic (dominant)
- pathogenic (recessive)
- pathogenic (!)
- pathogenic (maternal)
- pathogenic (paternal)
- likely pathogenic
- likely pathogenic (dominant)
- likely pathogenic (recessive)
- likely pathogenic (!)
- likely pathogenic (maternal)
- likely pathogenic (paternal)
- VUS
- VUS (!)
- likely benign
- likely benign (dominant)
- likely benign (recessive)
- likely benign (!)
- likely benign (maternal)
- likely benign (paternal)
- benign
- benign (dominant)
- benign (recessive)
- benign (!)
- benign (maternal)
- benign (paternal)
- conflicting
- association
- NA
DNA change (genomic) (hg19): HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38): HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN: description of the variant according to ISCN nomenclature
DB-ID: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID: ID of variant in ClinVar database
dbSNP ID: the dbSNP ID
Origin: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
- Germline
- De novo
- Germline/De novo (untested)
- Somatic
- Uniparental disomy
- Uniparental disomy, maternal allele
- Uniparental disomy, paternal allele
- CLASSIFICATION record
- SUMMARY record
- In vitro (cloned)
- In silico
- animal model
- Artefact
- DUPLICATE record
- Unknown
- Not applicable
Segregation: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
- ? = unknown
- yes = segregates with phenotype
- no = does not segregate with phenotype
- - = not applicable
Frequency: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Methylation: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)

 Effect
|

 Exon
|

 DNA change (cDNA)
|

 RNA change
|

 Protein
|

 P-domain
|

 Classification method
|

 Clinical classification
|

 DNA change (genomic) (hg19)
|

 DNA change (hg38)
|

 Published as
|

 ISCN
|

 DB-ID
|
 Variant remarks
|

 Reference
|

 ClinVar ID
|

 dbSNP ID
|

 Origin
|

 Segregation
|

 Frequency
|

 Re-site
|

 VIP
|

 Methylation
|

 Owner
|
+/. |
- |
c.(1-?)_(1144+1_1145-1)del |
r.? |
p.(?) |
- |
- |
pathogenic |
g.? |
- |
c.(1-?)_(1144+1_1145-1)del |
- |
SNRNP200_000007 |
- |
PubMed: Panneman 2023 |
- |
- |
Unknown |
- |
- |
- |
- |
- |
Daan Panneman |
+/. |
- |
c.(482+1_483-1)_(*127+?)del |
r.? |
p.(Ser161Argfs*35) |
- |
- |
pathogenic |
g.? |
- |
c.(482+1_483-1)_(*127+?)del |
- |
SNRNP200_000007 |
- |
PubMed: Panneman 2023 |
- |
- |
Unknown |
- |
- |
- |
- |
- |
Daan Panneman |
+?/. |
- |
p.0 |
r.0? |
p.0? |
- |
- |
likely pathogenic |
g.? |
g.? |
MERTK, variant 1: c.1689_1690+5delinsATATTA/p.?, variant 2 :Deletion entire gene |
- |
SNRNP200_000007 |
solved, compound heterozygous |
PubMed: Weisschuh 2020 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.-8163_1145-1213del |
r.? |
p.? |
- |
- |
pathogenic |
g.112648150_112739206del |
g.111890573_111981629del |
c.-8163_c.1145-1213del |
- |
MERTK_000208 |
- |
PubMed: Ellingford 2016 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+?/. |
1i_10i |
c.-8162_1145-1212del |
r.spl? |
p.? |
- |
- |
likely pathogenic |
g.112648151_112739207del |
- |
c.-8162_1145-1212del, p.? |
- |
MERTK_000209 |
- |
PubMed: Jonsson 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
1i_10i |
c.-8162_1145-1212del |
r.spl? |
p.? |
- |
- |
likely pathogenic |
g.112648151_112739207del |
- |
c.-8162_1145-1212del, p.? |
- |
MERTK_000209 |
- |
PubMed: Jonsson 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+/. |
_1_7i |
c.-8160_1145-1213del |
r.0? |
p.0? |
- |
- |
pathogenic |
g.112648153_112739206del |
g.111890576_111981629del |
hg18 112364622_112455675del91054 |
- |
MERTK_000040 |
91 kb deletion, founder mutation Faroe Island, represents 30% of RP |
PubMed: Ostergaard 2011 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
- |
c.(?_-1)_(1144+1_1145-1)del |
r.(?) |
p.(?) |
- |
ACMG |
pathogenic |
g.? |
g.? |
MERTK c.(?_-1) _(1144+1_1145-1)del c.(?_-1) _(1144+1_1145-1)del |
- |
SNRNP200_000007 |
homozygous |
PubMed: Jespersgaar 2019 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.(?_-1)_(1144+1_1145-1)del |
r.(?) |
p.(?) |
- |
ACMG |
likely pathogenic |
g.? |
g.? |
MERTK c.757+1G>A, p.(?) c.(?_-1) _(1144+1_1145-1)del |
- |
SNRNP200_000007 |
- |
PubMed: Jespersgaar 2019 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
+?/. |
2i_19_ |
c.(482+1_483-1)_*504{0} |
r.? |
p.? |
- |
- |
likely pathogenic |
g.(?_112702532)_(112786446_?)del |
- |
del ex3-19 |
- |
MERTK_000196 |
- |
PubMed: Ellingsford 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
_1_7i |
c.-122_(1144+1_1145-1){0} |
r.0? |
p.0? |
- |
- |
likely pathogenic |
g.(?_112656308)_(112733054_112740418)del |
- |
del ex1-7 |
- |
MERTK_000194 |
- |
PubMed: Ellingford 2017, PubMed: Ellingsford 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
_1_1i |
c.-122_(61+4262_?){0} |
r.0? |
p.0? |
- |
- |
likely pathogenic |
g.(?_112624327)_(112660635_?)del |
g.(?_111866750)_(111903058_?)del |
chr2:112624327_112660635del |
- |
MERTK_000190 |
range 59-36308 bp in various techniques, heterozygous |
PubMed: Zampaglione 2020 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.0 |
r.0? |
p.0? |
- |
- |
likely pathogenic |
g.111408390_113315808del |
g.110650813_112558231del |
arr[hg19] 2q13(111408390-113315808) del |
- |
MERTK_000175 |
compound heterozygous |
PubMed: Martin Merida 2019 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.0 |
r.(?) |
p.0 |
- |
ACMG |
pathogenic |
g.111371701_113132395del |
g.110614124_112374818del |
MERTK:NM_006343, |
- |
ACOXL_000006 |
heterozygous, individual solved, variant causal |
PubMed: Rodriguez-Munoz 2020 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.? |
r.? |
p.? |
- |
ACMG |
pathogenic |
g.? |
- |
NM_006343.2:c.62_3697del |
- |
SNRNP200_000007 |
- |
PubMed: Sharon 2019 |
- |
- |
Germline |
- |
1/2420 IRD families |
- |
- |
- |
Global Variome, with Curator vacancy |
+/. |
1i_19i |
c.? |
r.? |
p.? |
- |
- |
pathogenic (recessive) |
g.? |
- |
deletion ex2-19 |
- |
SNRNP200_000007 |
- |
PubMed: Birtel 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.? |
r.? |
p.? |
- |
- |
likely pathogenic |
g.? |
- |
del 13 genes incl. MERTK |
- |
SNRNP200_000007 |
- |
PubMed: Stone 2017 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.? |
r.(?) |
p.(?) |
- |
- |
likely pathogenic |
g.? |
g.? |
MERTK Partial deletion at 2q13 (77kb) |
- |
SNRNP200_000007 |
homozygous, partial deletion at 2q13 (77kb) |
PubMed: Jauregui 2020 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.? |
r.0? |
p.0? |
- |
- |
likely pathogenic |
g.112648147_112739204del |
- |
chr2:g.112648147_112739204del |
- |
SNRNP200_000007 |
heterozygous |
PubMed: Turro 2020 |
- |
- |
Germline/De novo (untested) |
? |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.? |
r.spl |
p.(?) |
- |
- |
likely pathogenic |
g.? |
g.? |
MERTK Multi-exon (3-19) deletion |
- |
SNRNP200_000007 |
heterozygous |
PubMed: Méjécase 2020 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+/. |
1 |
c.3G>A |
r.(?) |
p.(Met1?) |
- |
- |
pathogenic |
g.112656315G>A |
g.111898738G>A |
p.(Met1?) |
- |
MERTK_000041 |
- |
PubMed: Jinda 2016 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+?/. |
- |
c.3G>A |
r.(?) |
p.(Met1?) |
- |
- |
likely pathogenic |
g.112656315G>A |
- |
- |
- |
MERTK_000041 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
?/. |
- |
c.20C>T |
r.(?) |
p.(Pro7Leu) |
- |
- |
VUS |
g.112656332C>T |
- |
- |
- |
MERTK_000157 |
- |
PubMed: Sundaramurthy 2016 |
- |
- |
Germline |
no |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
1 |
c.35T>C |
r.(?) |
p.(Leu12Pro) |
signal peptide |
- |
pathogenic |
g.112656347T>C |
g.111898770T>C |
- |
- |
MERTK_000042 |
Align GVGD class C0; SIFT Deleterious (score: 0.04); Mutation Taster polymorphism (p-value: 1); Polyphen2 possibly damaging with a score of 0.910 |
PubMed: Tada 2006 |
- |
rs755593299 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
-?/. |
1 |
c.59G>C |
r.(?) |
p.(Arg20Thr) |
signal peptide |
- |
likely benign |
g.112656371G>C |
g.111898794G>C |
- |
- |
MERTK_000043 |
considered this variant as most likely not disease causing since Arg20Ser (rs35898499) has a MAF of 0.05467 and the residue is poorly conserved; Align GVGD class C0; SIFT tolerated (score 0.38); Mutation Taster polymorphism (p value=1); Polyphen2 benign with a score of 0 (sensitivity: 1.00; specificity: 0.00) with poor conservation (polymorphic residue with a Thr present in Opossum) |
PubMed: Tschernutter 2006 |
- |
rs552509122 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
1 |
c.60del |
r.(?) |
p.(Ala21Leufs*43) |
N-terminus |
- |
pathogenic |
g.112656372del |
g.111898795del |
- |
- |
MERTK_000044 |
putative compound hetetorzygous |
PubMed: Audo 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
1i |
c.61+1G>A |
r.spl |
p.? |
N-terminus |
- |
pathogenic |
g.112656374G>A |
g.111898797G>A |
- |
- |
MERTK_000045 |
- |
PubMed: Mackay 2010 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
-?/. |
- |
c.61+3G>C |
r.spl? |
p.? |
- |
- |
likely benign |
g.112656376G>C |
g.111898799G>C |
MERTK(NM_006343.2):c.61+3G>C |
- |
MERTK_000006 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
?/. |
- |
c.61+3G>C |
r.spl? |
p.? |
- |
- |
VUS |
g.112656376G>C |
g.111898799G>C |
- |
- |
MERTK_000006 |
- |
PubMed: Costa 2017 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+/. |
1i |
c.62-1G>A |
r.spl |
p.? |
N-terminus |
- |
pathogenic |
g.112686696G>A |
g.111929119G>A |
- |
- |
MERTK_000046 |
- |
PubMed: Wang 2014b |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+?/. |
- |
c.(61+1_62-1)_(482+1_483-1)dup |
r.(?) |
p.(?) |
- |
ACMG |
likely pathogenic |
g.? |
g.? |
MERTK c.(61+1_62-1)_(482+1_483-1)dup |
- |
SNRNP200_000007 |
single heterozygous variant (recessive) |
PubMed: Jespersgaar 2019 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
+?/. |
_2_19_,2 |
c.(61+1_62-1)_(*504_?)del |
r.(?) |
p.(?) |
- |
- |
likely pathogenic |
g.? |
g.? |
MERTK Deletion of exons 2-19, c.369C>G, p.Tyr123* |
- |
SNRNP200_000007 |
heterozygous |
PubMed: Gliem 2020 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+/. |
2 |
c.79G>T |
r.(?) |
p.(Glu27*) |
- |
ACMG |
pathogenic |
g.112686714G>T |
g.111929137G>T |
- |
- |
MERTK_000164 |
- |
Tracewska 2021, MolVis in press |
- |
- |
Germline |
yes |
0 (in-house database, ~5000 samples) |
- |
- |
- |
LOVD |
+/. |
2 |
c.79G>T |
r.(?) |
p.(Glu27*) |
- |
ACMG |
pathogenic |
g.112686714G>T |
g.111929137G>T |
- |
- |
MERTK_000164 |
- |
Tracewska 2021, MolVis in press |
- |
- |
Germline |
yes |
0 (in-house database, ~5000 samples) |
- |
- |
- |
LOVD |
+/. |
2 |
c.92_98del |
r.(?) |
p.(Pro31Argfs*31) |
- |
- |
pathogenic (recessive) |
g.112686727_112686733del |
g.111929150_111929156del |
91_97del |
- |
MERTK_000003 |
- |
PubMed: Wang 2014a |
- |
- |
Germline |
- |
- |
- |
- |
- |
Feng Wang |
?/. |
- |
c.98C>T |
r.(?) |
p.(Pro33Leu) |
- |
ACMG |
VUS |
g.112686733C>T |
- |
- |
- |
MERTK_000143 |
- |
PubMed: Al-Bdour 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
- |
c.98del |
r.(?) |
p.(Pro33Argfs*31) |
- |
- |
pathogenic |
g.112686733del |
g.111929156del |
c.98del, p.(Pro33Argfs*31) |
- |
MERTK_000176 |
compound heterozygous |
PubMed: Wang 2019 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
-?/. |
- |
c.102A>G |
r.(?) |
p.(Leu34=) |
- |
- |
likely benign |
g.112686737A>G |
g.111929160A>G |
MERTK(NM_006343.2):c.102A>G (p.L34=), MERTK(NM_006343.3):c.102A>G (p.L34=) |
- |
MERTK_000007 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
-/. |
- |
c.102A>G |
r.(?) |
p.(Leu34=) |
- |
- |
benign |
g.112686737A>G |
g.111929160A>G |
MERTK(NM_006343.2):c.102A>G (p.L34=), MERTK(NM_006343.3):c.102A>G (p.L34=) |
- |
MERTK_000007 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_AMC |
-?/. |
- |
c.107C>T |
r.(?) |
p.(Pro36Leu) |
- |
- |
likely benign |
g.112686742C>T |
g.111929165C>T |
MERTK(NM_006343.2):c.107C>T (p.P36L), MERTK(NM_006343.3):c.107C>T (p.P36L) |
- |
MERTK_000008 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_AMC |
-?/. |
- |
c.107C>T |
r.(?) |
p.(Pro36Leu) |
- |
- |
likely benign |
g.112686742C>T |
- |
MERTK(NM_006343.2):c.107C>T (p.P36L), MERTK(NM_006343.3):c.107C>T (p.P36L) |
- |
MERTK_000008 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+/. |
- |
c.224del |
r.(?) |
p.(Thr75Lysfs*4) |
- |
- |
pathogenic |
g.112686859del |
g.111929282del |
- |
- |
MERTK_000106 |
- |
PubMed: Koyanagi 2019, Journal: Koyanagi 2019 |
- |
rs527236083 |
Germline |
- |
1/1204 cases with retinitis pigmentosa |
- |
- |
- |
Yoshito Koyanagi |
+/. |
2 |
c.225del |
r.(?) |
p.(Gly76Glufs*3) |
N-terminus fragment |
- |
pathogenic |
g.112686860del |
g.111929283del |
- |
- |
MERTK_000047 |
- |
PubMed: Oishi 2014 |
- |
rs527236083 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
- |
c.225del |
r.(?) |
p.(Gly76GlufsTer3) |
- |
- |
pathogenic |
g.112686860del |
g.111929283del |
225delA |
- |
MERTK_000047 |
- |
PubMed: Oishi 2014 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.225del |
r.(?) |
p.(Gly76GlufsTer3) |
- |
- |
pathogenic |
g.112686860del |
g.111929283del |
225delA |
- |
MERTK_000047 |
- |
PubMed: Oishi 2014 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
4 |
c.225del |
r.(?) |
p.(Pro76Glnfs*3) |
- |
- |
likely pathogenic (recessive) |
g.112686860del |
- |
c.225delA |
- |
MERTK_000047 |
- |
PubMed: Liu-2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
2 |
c.225delA |
r.(?) |
p.(Gly76Glufs*3) |
- |
ACMG |
likely pathogenic |
g.111929283del |
g.111929283del |
MERTK c.225delA, p.Thr75Thrfs4, homozygous |
- |
MERTK_000191 |
error in annotation: c.225delA causes p.(Gly76GlufsTer3), and not p.(Thr75Thrfs4) |
PubMed: Sun 2020 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
-?/. |
- |
c.231C>T |
r.(?) |
p.(Asn77=) |
- |
- |
likely benign |
g.112686866C>T |
- |
MERTK(NM_006343.3):c.231C>T (p.N77=) |
- |
MERTK_000172 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_AMC |
+?/. |
5 |
c.263C>T |
r.(?) |
p.(Ala88Val) |
- |
- |
likely pathogenic |
g.112686898C>T |
- |
c.263C>T p.(Ser88Leu) |
- |
MERTK_000195 |
- |
PubMed: Ellingsford 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
5 |
c.263C>T |
r.(?) |
p.(Ala88Val) |
- |
- |
likely pathogenic |
g.112686898C>T |
- |
c.263C>T p.(Ser88Leu) |
- |
MERTK_000195 |
- |
PubMed: Ellingsford 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
-?/. |
- |
c.276G>A |
r.(?) |
p.(Pro92=) |
- |
- |
likely benign |
g.112686911G>A |
- |
MERTK(NM_006343.2):c.276G>A (p.P92=) |
- |
MERTK_000214 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/. |
- |
c.296_297del |
r.(?) |
p.(Thr99Serfs*8) |
- |
- |
likely pathogenic |
g.112686931_112686932del |
g.111929354_111929355del |
296_297delCA |
- |
MERTK_000154 |
- |
PubMed: Huang 2017 |
- |
- |
Unknown |
- |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.296_297del |
r.(?) |
p.(Thr99Serfs*8) |
- |
- |
likely pathogenic |
g.112686931_112686932del |
g.111929354_111929355del |
c.291_292delAC |
- |
MERTK_000154 |
- |
PubMed: Huang 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+/. |
2 |
c.296_297del |
r.(?) |
p.(Thr99Serfs*8) |
- |
ACMG |
pathogenic |
g.112686931_112686932del |
g.111929354_111929355del |
NM_006343.2:c.296_297del, NP_006334.2:p.(Thr99SerfsTer8), NC_000002.11:g.112686931_112686932del |
- |
MERTK_000154 |
- |
PubMed: Wang 2018 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
+?/. |
5 |
c.296_297del |
r.(?) |
p.(Val100Alafs*13) |
- |
- |
likely pathogenic (recessive) |
g.112686931_112686932del |
- |
c.296_297delCA |
- |
MERTK_000154 |
- |
PubMed: Liu-2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
5 |
c.296_297del |
r.(?) |
p.(Val100Alafs*13) |
- |
- |
likely pathogenic (recessive) |
g.112686931_112686932del |
- |
c.296_297delCA |
- |
MERTK_000154 |
- |
PubMed: Liu-2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
5 |
c.296_297del |
r.(?) |
p.(Val100Alafs*13) |
- |
- |
likely pathogenic (recessive) |
g.112686931_112686932del |
- |
c.291_292delAC |
- |
MERTK_000154 |
- |
PubMed: Liu-2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.296_297del |
r.(?) |
p.(Thr99Serfs*8) |
- |
ACMG |
pathogenic |
g.112686931_112686932del |
g.111929354_111929355del |
MERTK c.296_297del(;)499C>G, V1: c.296_297delCA, (p.Thr99SerfsTer8) |
- |
MERTK_000154 |
alleles in cis or trans; heterozygous |
PubMed: Chen 2021 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.296_297del |
r.(?) |
p.(Thr99Serfs*8) |
- |
ACMG |
pathogenic |
g.112686931_112686932del |
g.111929354_111929355del |
MERTK c.296_297del(;)1988_1989insAT, V2: c.296_297delCA, (p.Thr99SerfsTer8) |
- |
MERTK_000154 |
alleles in cis or trans; heterozygous |
PubMed: Chen 2021 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.296_297delCA |
r.(?) |
p.(Thr99SerfsTer8) |
- |
- |
pathogenic |
g.112686931_112686932del |
g.111929354_111929355del |
MERTK c.296_297del(;)499C>G; p.(Thr99SerfsTer8) |
- |
MERTK_000154 |
heterozygous |
PubMed: Chen 2021 |
- |
- |
Germline/De novo (untested) |
? |
Taiwan Biobank: delAC:0.000330; GnomAD_exome_East: 0.000109; GnomAD_All: 0.0000119 |
- |
- |
- |
LOVD |
+/. |
- |
c.296_297delCA |
r.(?) |
p.(Thr99SerfsTer8) |
- |
- |
pathogenic |
g.112686931_112686932del |
g.111929354_111929355del |
MERTK c.296_297del(;)1988_1989insAT; p.(Thr99SerfsTer8) |
- |
MERTK_000154 |
heterozygous |
PubMed: Chen 2021 |
- |
- |
Germline/De novo (untested) |
? |
Taiwan Biobank: 0.000330; GnomAD_exome_East: 0.000109; GnomAD_All: 0.0000119 |
- |
- |
- |
LOVD |
+/. |
2 |
c.308_309del |
r.(?) |
p.(Ile103Asnfs*4) |
Ig-like C2 type I |
- |
pathogenic |
g.112686943_112686944del |
g.111929366_111929367del |
- |
- |
MERTK_000048 |
- |
PubMed: Yang 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
2 |
c.325A>T |
r.(?) |
p.(Lys109*) |
Ig-like C2 type I |
- |
pathogenic |
g.112686960A>T |
g.111929383A>T |
- |
- |
MERTK_000049 |
- |
PubMed: Patel 2016 |
- |
rs786205533 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
2 |
c.343T>G |
r.(?) |
p.(Cys115Gly) |
Ig-like C2 type I |
- |
pathogenic |
g.112686978T>G |
g.111929401T>G |
- |
- |
MERTK_000050 |
no variant found 2nd chromosome;A lign GVGD class C65; SIFT deleterious (score 0); Mutation Taster disease causing (p value=1); Polyphen2 probably damaging with a score of 1 (sensitivity: 0.00; specificity: 1.00) and conserved residue |
PubMed: Tada 2006 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
- |
c.343T>G |
r.(?) |
p.(Cys115Gly) |
- |
- |
pathogenic |
g.112686978T>G |
g.111929401T>G |
- |
- |
MERTK_000050 |
- |
PubMed: Koyanagi 2019, Journal: Koyanagi 2019 |
- |
- |
Germline |
- |
1/1204 cases with retinitis pigmentosa |
- |
- |
- |
Yoshito Koyanagi |
?/. |
6 |
c.343T>G |
r.(?) |
p.(Cys115Gly) |
- |
- |
VUS |
g.112686978T>G |
- |
c.343T>G |
- |
MERTK_000050 |
- |
PubMed: Panneman 2023 |
- |
- |
Unknown |
- |
- |
- |
- |
- |
Daan Panneman |
?/. |
2 |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
Ig-like C2 type I |
- |
VUS |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
- |
PubMed: Wang 2014b |
- |
rs772421550 |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
2 |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
Ig-like C2 type I |
- |
pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
Align GVGD class C65; SIFT deleterious (score 0); Mutation Taster disease causing (p value=1); Polyphen2 probably damaging with a score of 1 (sensitivity: 0.00; specificity: 1.00) and conserved residue |
Khan 2018 |
- |
rs772421550 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
2 |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
Ig-like C2 type I |
- |
pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
Align GVGD class C65; SIFT deleterious (score 0); Mutation Taster disease causing (p value=1); Polyphen2 probably damaging with a score of 1 (sensitivity: 0.00; specificity: 1.00) and conserved residue |
PubMed: Eisenberger 2013 |
- |
rs772421550 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
2 |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
Ig-like C2 type I |
- |
pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
putative compound hetetorzygous;A lign GVGD class C65; SIFT deleterious (score 0); Mutation Taster disease causing (p value=1); Polyphen2 probably damaging with a score of 1 (sensitivity: 0.00; specificity: 1.00) and conserved residue |
PubMed: Audo 2018 |
- |
rs772421550 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+?/. |
- |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
- |
likely pathogenic |
g.112686980C>G |
g.111929403C>G |
MERTK(NM_006343.3):c.345C>G (p.C115W) |
- |
MERTK_000051 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_AMC |
+?/. |
- |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
- |
pathogenic (recessive) |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
- |
PubMed: Avela 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
- |
likely pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
- |
PubMed: Stone 2017 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
- |
pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
- |
PubMed: Khan 2017 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
2 |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
ACMG |
likely pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
- |
Tracewska 2021, MolVis in press |
- |
- |
Germline |
- |
0 (in-house database, ~5000 samples) |
- |
- |
- |
LOVD |
+?/. |
2 |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
ACMG |
likely pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
- |
Tracewska 2021, MolVis in press |
- |
- |
Germline |
yes |
0 (in-house database, ~5000 samples) |
- |
- |
- |
LOVD |
+?/. |
2 |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
ACMG |
likely pathogenic |
g.112686980C>G |
g.111929403C>G |
- |
- |
MERTK_000051 |
- |
Tracewska 2021, MolVis in press |
- |
- |
Germline |
yes |
0 (in-house database, ~5000 samples) |
- |
- |
- |
LOVD |
+/. |
6 |
c.345C>G |
r.(?) |
p.(Ser115Arg) |
- |
- |
pathogenic |
g.112686980C>G |
- |
c.345C>G |
- |
MERTK_000051 |
- |
PubMed: Eisenberger-2013 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.345C>G |
r.(?) |
p.(Cys115Trp) |
- |
ACMG |
likely pathogenic |
g.112686980C>G |
g.111929403C>G |
MERTK c.345C>G, p.(Cys115Trp), c.345C>G, p.(Cys115Trp) |
- |
MERTK_000051 |
homozygous |
PubMed: Jespersgaar 2019 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
+/. |
- |
c.346_349delTCAA |
r.(?) |
p.(Ile117Valfs*39) |
- |
ACMG |
pathogenic |
g.112686984_112686987del |
g.111929407_111929410del |
MERTK NM_006343: g.30926_30929delTCAA, c.346_349delTCAA, p.I117Vfs39 |
- |
MERTK_000179 |
- |
PubMed: Xu 2020 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
LOVD |
-/. |
- |
c.353G>A |
r.(?) |
p.(Ser118Asn) |
- |
- |
benign |
g.112686988G>A |
g.111929411G>A |
MERTK(NM_006343.3):c.353G>A (p.S118N) |
- |
MERTK_000009 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Groningen |
-/. |
- |
c.353G>A |
r.(?) |
p.(Ser118Asn) |
- |
- |
benign |
g.112686988G>A |
g.111929411G>A |
- |
- |
MERTK_000009 |
- |
PubMed: Koyanagi 2019, Journal: Koyanagi 2019 |
- |
rs13027171 |
Germline |
- |
229/1204 cases with retinitis pigmentosa |
- |
- |
- |
Yoshito Koyanagi |
-/. |
- |
c.353G>A |
r.(?) |
p.(Ser118Asn) |
- |
- |
benign |
g.112686988G>A |
g.111929411G>A |
- |
- |
MERTK_000009 |
- |
PubMed: Koyanagi 2019, Journal: Koyanagi 2019 |
- |
rs13027171 |
Germline |
- |
16/1204 cases with retinitis pigmentosa |
- |
- |
- |
Yoshito Koyanagi |
+/. |
2 |
c.369C>G |
r.(?) |
p.(Tyr123*) |
- |
- |
pathogenic (recessive) |
g.112687004C>G |
g.111929427C>G |
- |
- |
MERTK_000146 |
- |
PubMed: Birtel 2018 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
2 |
c.369C>G |
r.(?) |
p.(Tyr123*) |
- |
- |
likely pathogenic |
g.112687004C>G |
g.111929427C>G |
MERTK Deletion of exons 2-19 c.369C>G, p.? p.Tyr123* |
- |
MERTK_000146 |
hemizygous (apparent homozygosity because of lack of second sequence on the other allele |
PubMed: Gliem 2020 |
- |
- |
Unknown |
? |
- |
- |
- |
- |
LOVD |
+/. |
2 |
c.370C>T |
r.(?) |
p.(Gln124*) |
Ig-like C2 type I |
- |
pathogenic |
g.112687005C>T |
g.111929428C>T |
- |
- |
MERTK_000052 |
- |
PubMed: Oishi 2014 |
- |
rs527236134 |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+/. |
2 |
c.390G>A |
r.(?) |
p.(Trp130*) |
- |
- |
pathogenic (recessive) |
g.112687025G>A |
g.111929448G>A |
- |
- |
MERTK_000002 |
- |
PubMed: Wang 2014a |
- |
- |
Germline |
- |
- |
- |
- |
- |
Feng Wang |
+/. |
2 |
c.390G>A |
r.(?) |
p.(Trp130*) |
Ig-like C2 type I |
- |
pathogenic |
g.112687025G>A |
g.111929448G>A |
- |
- |
MERTK_000002 |
- |
PubMed: Ge 2015 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Isabelle Audo |
+?/. |
2 |
c.390G>A |
r.(?) |
p.(Trp130*) |
- |
- |
likely pathogenic |
g.112687025G>A |
g.111929448G>A |
c.390G>A, p.(Trp130*) |
- |
MERTK_000002 |
Homozygous |
PubMed: Tayebi 2019 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
LOVD |
?/. |
- |
c.390G>A |
r.(?) |
p.(Trp130*) |
- |
- |
VUS |
g.112687025G>A |
g.111929448G>A |
MERTK nucleotide 1, protein 1:c.390G>A, p.Trp130* nucleotide 2, protein 2:c.1605-2A>G, p.? |
- |
MERTK_000002 |
heterozygous, ACMG unclassified - no access to supplementary table 2 |
PubMed: Hull 2020 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
+/. |
6 |
c.392G>A |
r.(?) |
p.(Gly131Asp) |
- |
- |
pathogenic |
g.112687027G>A |
- |
c.392G>A |
- |
MERTK_000200 |
- |
PubMed: Salmaninejad-202 |
- |
- |
Unknown |
- |
- |
- |
- |
- |
LOVD |
+?/. |
6 |
c.392G>A |
r.(?) |
p.(Trp131*) |
- |
- |
likely pathogenic |
g.112687027G>A |
- |
c.392G>A |
- |
MERTK_000200 |
- |
PubMed: Liu 2018 |
- |
- |
De novo |
- |
- |
- |
- |
- |
LOVD |
?/. |
- |
c.436C>G |
r.(?) |
p.(Gln146Glu) |
- |
ACMG |
VUS |
g.112687071C>G |
g.111929494C>G |
MERTK:NM_006343 c.C436G, p.Q146E |
- |
MERTK_000189 |
heterozygous, individual unsolved, causality of variants unknown |
PubMed: Rodriguez-Munoz 2020 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.436C>T |
r.(?) |
p.(Gln146Ter) |
- |
ACMG |
likely pathogenic (recessive) |
g.112687071C>T |
g.111929494C>T |
- |
- |
MERTK_000224 |
ACMG PVS1, PM2 |
PubMed: Basharat 2024 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Rabia Basharat |
+?/. |
- |
c.436C>T |
r.(?) |
p.(Gln146Ter) |
- |
ACMG |
likely pathogenic (recessive) |
g.112687071C>T |
g.111929494C>T |
- |
- |
MERTK_000224 |
ACMG PVS1, PM2 |
PubMed: Basharat 2024 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Rabia Basharat |
+?/. |
- |
c.436C>T |
r.(?) |
p.(Gln146Ter) |
- |
ACMG |
likely pathogenic (recessive) |
g.112687071C>T |
g.111929494C>T |
- |
- |
MERTK_000224 |
ACMG PVS1, PM2 |
PubMed: Basharat 2024 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Rabia Basharat |
+?/. |
- |
c.436C>T |
r.(?) |
p.(Gln146Ter) |
- |
ACMG |
likely pathogenic (recessive) |
g.112687071C>T |
g.111929494C>T |
- |
- |
MERTK_000224 |
ACMG PVS1, PM2 |
PubMed: Basharat 2024 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Rabia Basharat |
+?/. |
- |
c.436C>T |
r.(?) |
p.(Gln146Ter) |
- |
ACMG |
likely pathogenic (recessive) |
g.112687071C>T |
g.111929494C>T |
- |
- |
MERTK_000224 |
ACMG PVS1, PM2 |
PubMed: Basharat 2024 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Rabia Basharat |
+?/. |
- |
c.436_437del |
r.(?) |
p.(Gln146Valfs*5) |
- |
- |
likely pathogenic |
g.112687071_112687072del |
g.111929494_111929495del |
433_434delAC |
- |
MERTK_000155 |
- |
PubMed: Stone 2017 |
- |
- |
Germline |
- |
- |
- |
- |
- |
LOVD |
+?/. |
- |
c.436_437del |
r.(?) |
p.(Gln146Valfs*5) |
- |
- |
likely pathogenic |
g.112687071_112687072del |
g.111929494_111929495del |
c.436_437delCA |
- |
MERTK_000155 |
- |
PubMed: Hariri 2018 |
- |
- |
Germline |
? |
- |
- |
- |
- |
LOVD |